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Where Are We Now?
W
ith increasing pressure on
healthcare budgets around
the globe, it is vital for
healthcare providers to demonstrate
that their procedures deliver value [8].
If we want to improve the value of
healthcare, we will need to institute
substantial cost-saving measures [3].
Adverse events in hospitals are esti-
mated to affect one in 10 patients [2],
and the economic impact of events like
infections, adverse-drug events, and
surgical complications is substantial. If
we could reduce their frequency, cost
savings would likely follow.
There are potential risk factors for
complications following total shoulder
arthroplasty [1], a procedure that has
more than tripled in incidence in the last
10 years [6]. Reducing adverse events
and readmissions after surgery are two
key areas that warrant close attention
when improving surgical services [4, 5].
The current study by Bernstein and
colleagues compared two models that
predict unplanned readmission rates and
adverse events after total shoulder
arthroplasty. Traditionally, clinicians
identify potential risk factors by high-
lighting the phenotypic traits of their
patients and subjecting the data to
regression analyses. The disadvantage to
this is that other factors deemed unim-
portant might be overlooked. By
preoperatively identifying patients with
characteristics thatmight lead to a higher
risk of adverse events or readmissions,
these models can potentially modify the
risk factors ahead of treatment.
Where Do We Need To Go?
According to the current study, statis-
tically derived risk-stratification
models perform better than those
derived from clinical suspicion alone.
However, it is still unclear how accu-
rate, comprehensive, or appropriate the
variables collected within large data-
bases can be. When working with large
databases, we have to balance the
inclusion of too many variables (risk-
ing in inclusion of inaccurate data),
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with the omission of data that might
identify crucial clinical characteristics.
One area of concern is knowing what
todowith the risk factors identified in the
preoperative period. Some might be
modifiable, such as those in studies that
demonstrated the benefits of quitting
smoking [8]. However, many of the
variables identified in the current study
may not be modifiable. Does this mean
that we prevent elderly males from
undergoing total shoulder arthroplasty
due to their risk for complications and
readmissions? Do we introduce an
additional cost proportional to their
identified high-risk status? With
increased operating time identified as a
risk factor for adverse events in this
study, should we be assessing surgeons’
speed of operating? (I suspect this
statistic relates to intraoperative com-
plications slowing operative time, rather
than the sluggishness of the clinician.)
Data from large databases is only an
asset if it is relevant and usable. To
enhance the data we extract from such
databases, it will be essential to gain a
consensus on content and variables
that need collecting. We also need to
know how to effectively process data
to provide knowledge for clinicians
and benefits for our patients.
How Do We Get There?
A previous study on national arthro-
plasty registers highlighted the
importance of a collaborative approach
to using databases [7]. However, this
study highlighted the inconsistences of
datasets from various contributing
sources. We need to aspire towards
international standardization of the
most appropriate variables to include
in large databases. There will need to
be thorough validation of these items,
how they relate to patient outcomes,
and their relevance in the population of
interest. The content of databases
should be developed through collabo-
ration between national societies,
organizations and registry groups
which in turn should improve stan-
dards of data collections and data
quality.
Instead of needing copious ran-
domized trials to explore the concept
of risk stratification and ‘‘evidence-
based practice,’’ it will be ‘‘practice-
based evidence’’—using robust,
prospectively maintained databa-
ses—that will prevail and be the more
successful strategy. Prospective studies
could identify strategies to modify the
risk factors associated with total
shoulder arthroplasty, as well as
determine whether identifying risk
factors does indeed modify the out-
come for this patient population.
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